Impact of Right Atrial Occlusion on TEVAR Outcomes

Launched by UNIVERSITY OF CALGARY · Jan 20, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how a specific technique, called right atrial occlusion, affects the outcomes of a procedure known as thoracic endovascular aortic repair (TEVAR). TEVAR is used to treat problems with the thoracic aorta, such as aneurysms or dissections. The researchers want to understand if using right atrial occlusion during this procedure leads to better results for patients compared to other methods that also aim to reduce the aortic impulse, which is the pressure and movement inside the aorta during surgery. By gathering data from a large number of TEVAR patients, the study hopes to provide insights that could improve surgical practices and outcomes for future patients.

To be eligible for this trial, participants need to be at least 18 years old and scheduled for a TEVAR procedure that includes the use of right atrial balloon occlusion. Patients who are younger than 18, those undergoing other types of aortic repair, or those who are not using the right atrial technique will not be included. If you join the study, you can expect to be part of a group that is closely monitored during and after the TEVAR procedure to see how the right atrial occlusion impacts your recovery and overall health. This research could play a significant role in shaping how doctors approach TEVAR in the future, ultimately aiming to enhance patient care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age 18 years or older
• • thoracic endovascular aortic repair
• • right atrial balloon occlusion for reduction or elimination of aortic impulse
• • endograft deployment in landing zones 0-3
• Exclusion Criteria:
• • age 18 years or younger
• • non-thoracic endovascular aortic repair
• • reduction or elimination of aortic impulse using technique other than right atrial balloon occlusion
• • endograft deployment in landing zones 4 and beyond